Skip to main content

Want a detailed portfolio tracker?

uniQure N.V. (QURE) P/E (2016 - 2026)

uniQure N.V. (QURE) P/E from Mar 31, 2016 to Jul 21, 2026. The TTM uniQure N.V. (QURE) P/E is -11.70. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of uniQure N.V. (QURE)

YearP/EChange
2026-11.70+65.02%
2025-7.09+97.31%
2024-3.59+154.18%
2023-1.41-83.27%
2022-8.45-391.61%
20212.90-122.57%
2020-12.84-45.27%
2019-23.46+96.74%
2018-11.93+58.78%
2017-7.51+223.36%
2016-2.32N/A

Comparison uniQure N.V. (QURE) P/E with competitors

uniQure N.V. (QURE) P/E is -11.70.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.64%
FGENFibroGen Inc0.24-102.05%
CHRSCoherus Biosciences Inc0.85-107.25%
FBIOFortress Biotech Inc0.95-108.11%
ORMPOramed Pharmaceuticals Inc1.50-112.85%
AGENAgenus Inc3.01-125.73%
INVAInnoviva Inc3.15-126.96%
VXRTVaxart Inc3.55-130.34%
CRMDCorMedix Inc3.63-131.02%
CVACCureVac N.V.4.45-138.00%
GLPGGalapagos NV4.86-141.54%
SRPTSarepta Therapeutics Inc4.88-141.73%
ABEOAbeona Therapeutics Inc5.39-146.05%
ABUSArbutus Biopharma Corp5.60-147.83%
ZVRAZevra Therapeutics Inc5.89-150.33%
SPROSpero Therapeutics Inc6.23-153.24%
CGENCompugen Ltd6.31-153.97%
RIGLRigel Pharmaceuticals6.87-158.74%
SLXNSilexion Therapeutics Corp7.30-162.37%
OMEROmeros Corporation9.26-179.15%
AUPHAurinia Pharmaceuticals Inc9.58-181.93%
PLXProtalix BioTherapeutics Inc10.89-193.10%
ACADAcadia Pharmaceuticals Inc11.73-200.26%
TBPHTheravance Biopharma Inc12.26-204.82%
ADMAAdma Biologics Inc12.42-206.15%
HRMYHarmony Biosciences Holdings Inc13.82-218.14%
SABSSAB Biotherapeutics Inc14.14-220.84%
NAGENiagen Bioscience Inc14.82-226.67%
INCYIncyte Corp15.82-235.26%
REGNRegeneron Pharmaceuticals Inc15.86-235.55%
PBYIPuma Biotechnology Inc17.32-248.02%
CPRXCatalyst Pharmaceuticals Inc17.44-249.08%
EXELExelixis Inc17.54-249.92%
TGTXTG Therapeutics Inc18.97-262.13%
MDXGMimedx Group Inc20.55-275.69%
XOMAXOMA Royalty Corp22.87-295.54%
ARGXArgen X SE24.30-307.71%
CTMXCytomX Therapeutics Inc24.82-312.18%
XOMAOXOMA Royalty Corp25.34-316.66%
HALOHalozyme Therapeutics Inc25.62-319.04%
XOMAPXOMA Royalty Corp25.67-319.44%
VRTXVertex Pharmaceuticals Inc27.99-339.31%
RPRXRoyalty Pharma plc - Class A28.69-345.24%
SLNOSoleno Therapeutics Inc29.02-348.04%
ASNDAscendis Pharma A/S30.09-357.19%
LGNDLigand Pharmaceuticals Inc - Class B37.91-424.09%
APLSApellis Pharmaceuticals Inc39.02-433.57%
BMRNBiomarin Pharmaceutical Inc42.21-460.85%
KRYSKrystal Biotech Inc45.34-487.62%
ONCBeiGene Ltd69.54-694.47%
PHARPharming Group N.V.75.03-741.36%
TECHBio-Techne Corp101.96-971.59%
VCELVericel Corp109.92-1039.67%
ALNYAlnylam Pharmaceuticals Inc117.96-1108.43%
GMABGenmab140.29-1299.28%
TLXTelix Pharmaceuticals Ltd162.15-1486.17%
CORTCorcept Therapeutics Inc212.86-1919.62%